Pediatrics Clinical Trial
Official title:
Population Pharmacokinetics Of Ceftazidime, Ciprofloxacin And Voriconazole In Paediatric Young Patients (< 12 Years Old)
The Pharm A project is a French national collaborative project aiming to determine the population pharmacokinetics of ceftazidime, ciprofloxacin, and voriconazole in paediatric patients aged one month to five years.
The licensing process was introduced in order to ensure that medicines are safe, effective
and of high quality. However, over 50% of children admitted to hospital in France and Europe
will receive an unlicensed or off-label medicine. This occurs for most drugs in children
less than 6 years of age. They represent a particularly vulnerable subgroup of the
paediatric population.
There are major practical and ethical issues in relation to studying medicines in paediatric
patients aged 5 years or less.
- They represent only a small part of the population as compared to older children and
adults, and the variation of specific types of diseases in this young subpopulation is
higher than in the paediatric counterpart. There are major differences in drug
disposition in the different age groups.
- There is a need for suitable methodological approaches for clinical trials
- There are major ethical issues It is essential, therefore, to recruit children from
various regions in France in order to obtain a critical sample size of sufficient
magnitude and to conduct scientific sound studies. This will be achieved by performing
Pharm A, a population pharmacokinetic study of three different anti infectious agents
(ceftazidime, ciprofloxacin, voriconazole) and identify covariates including
pharmacogenetic biomarkers that explain pharmacokinetic variability.
After parental informed consent, sampling strategy will be randomized depending on the drug
and the age group (2 samples in patients below 2 years and 3 samples in patients from 2 to 5
years).
;
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05975658 -
WIReD: Wireless Interstage Remote Device Study
|
||
Completed |
NCT03921346 -
Reducing Prehospital Medication Errors & Time to Drug Delivery by EMS During Simulated Pediatric CPR
|
N/A | |
Not yet recruiting |
NCT04087070 -
Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
|
||
Completed |
NCT04301206 -
Videos and Simple Text to Empower Parents to Handle Their Sick Children
|
N/A | |
Recruiting |
NCT06273228 -
Parenting Young Children in Pediatrics
|
N/A | |
Recruiting |
NCT05480930 -
Improving Nighttime Access to Care and Treatment; Part 4-Haiti
|
N/A | |
Not yet recruiting |
NCT05815563 -
Validation of Peripheral Perfusion Index in Predicting Successful Supraclavicular Brachial Plexus Block in Pediatrics
|
||
Recruiting |
NCT02556541 -
Ultrasound-guided Peripheral Vascular Access in Children
|
N/A | |
Recruiting |
NCT02908113 -
Visual Perception in Preterm Infants
|
N/A | |
Not yet recruiting |
NCT01678066 -
A Prospective Study to Bilaterally Compare a Non-Invasive Cardiac Output Monitor
|
N/A | |
Completed |
NCT04993599 -
Evaluation of Social Robot Usability for Pediatric Patients and Carers
|
N/A | |
Completed |
NCT05537168 -
Bayesian Networks in Pediatric Cardiac Surgery
|
||
Completed |
NCT01603628 -
BOTOX® Treatment in Pediatric Lower Limb Spasticity
|
Phase 3 | |
Completed |
NCT01603615 -
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
|
Phase 3 | |
Completed |
NCT06098105 -
Laparoscopic vs Ultrasound-Guided Transversus Abdominis Plane Block vs Laparoscopic Intraperitoneal Instillation of Local Anesthetic in Pediatrics
|
N/A | |
Completed |
NCT01418846 -
Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients
|
N/A | |
Completed |
NCT01460329 -
Comparing Cardiac Output Measurements in Critically Ill Children Using USCOM and Transthoracic ECHO
|
N/A | |
Withdrawn |
NCT00666393 -
An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients
|
Phase 3 | |
Recruiting |
NCT03337581 -
Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric
|
Phase 4 | |
Recruiting |
NCT05275881 -
Impact of Virtual Reality in Pediatric Hematology and Oncology
|
N/A |